Stock RYTM RHYTHM PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Rhythm Pharmaceuticals, Inc.

Equities

RYTM

US76243J1051

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-19 pm EDT 		5-day change 1st Jan Change
38.01 USD -0.26% Intraday chart for Rhythm Pharmaceuticals, Inc. -5.75% -17.32%
Apr. 18 Wells Fargo Trims Price Target on Rhythm Pharmaceuticals to $52 From $53, Maintains Overweight Rating MT
Apr. 01 Rhythm Pharmaceuticals to Sell $150 Million in Series A Convertible Preferred Stock MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Wells Fargo Trims Price Target on Rhythm Pharmaceuticals to $52 From $53, Maintains Overweight Rating
MT
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
GL
Rhythm Pharmaceuticals to Sell $150 Million in Series A Convertible Preferred Stock
MT
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
GL
Rhythm Pharmaceuticals, Inc. announced that it expects to receive $150 million in funding from Perceptive Advisors LLC, C2 Life Sciences, Llc, Perceptive Discovery ID LP
CI
Rhythm Pharmaceuticals Doses First Patients in Phase 1 Trial of Potential Obesity Therapy
MT
Rhythm Pharmaceuticals Announces First Patient Dosed in Phase 1 Trial Evaluating RM-718, a Weekly MC4R-specific Agonist
GL
Rhythm Pharmaceuticals Announces First Patient Dosed in Phase 1 Trial Evaluating RM-718, a Weekly MC4R-specific Agonist
AQ
Rhythm Pharmaceuticals Announces First Patient Dosed in Phase 1 Trial Evaluating RM-718, a Weekly MC4R-specific Agonist
CI
Rhythm Pharmaceuticals Insider Sold Shares Worth $735,600, According to a Recent SEC Filing
MT
Rhythm Pharmaceuticals Insider Sold Shares Worth $707,005, According to a Recent SEC Filing
MT
Perceptive Advisors Engages in Discussion with Rhythm Pharmaceuticals
CI
Rhythm Pharmaceuticals Insider Sold Shares Worth $608,498, According to a Recent SEC Filing
MT
Rhythm Pharmaceuticals Insider Sold Shares Worth $627,520, According to a Recent SEC Filing
MT
Rhythm Pharmaceuticals Insider Sold Shares Worth $608,498, According to a Recent SEC Filing
MT
Rhythm Pharmaceuticals Insider Sold Shares Worth $608,498, According to a Recent SEC Filing
MT
Rhythm Pharmaceuticals Insider Sold Shares Worth $608,498, According to a Recent SEC Filing
MT
Transcript : Rhythm Pharmaceuticals, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-14-2024 07:30 AM
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
GL
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RYTM Stock
  4. News Rhythm Pharmaceuticals, Inc.